对肺癌预后基因表达数据的聚类方法进行比较研究
1Wake Forest University, Winston-Salem, NC, United States of America.
BMC research notes
|November 8, 2023
概括
监督和半监督的集群方法有效地识别出具有显著生存差异的肺癌亚型,优于针对个性化治疗策略的传统无监督方法.
科学领域:
- 计算生物学是一种计算生物学.
- 基因组学就是基因组学.
- 癌症研究 癌症研究
背景情况:
- 使用基因表达的肺癌亚型鉴定对于个性化治疗至关重要.
- 传统的无监督集群可能与患者生存结果不一致.
研究的目的:
- 为了比较无监督,半监督和监督的集群方法来识别临床预后肺癌亚型.
- 评估已识别的集群对患者生存预后的相关性.
主要方法:
- 在两个肺腺癌数据集中应用了无监督,半监督和监督的集群.
- 按方法将患者分成两组.
- 通过使用logrank p值来评估群集之间的生存差异.
主要成果:
- 没有监督的方法产生了非显著的生存差异 (较大的logrank p值).
- 半监督和监督方法表现出显著改善的性能,具有非常显著的p值.
- 监督和半监督方法确定了临床相关的亚型.
结论:
- 无监督的聚类不足以确定生存相关的肺癌亚型.
- 半监督和监督方法是基于基因表达和生存数据发现临床有用的肺癌亚型的优势.
相关概念视频
Statistical Methods for Analyzing Epidemiological Data
382
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
382
Comparing the Survival Analysis of Two or More Groups
200
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
200
Cancer Survival Analysis
357
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
357


